STRO — Sutro Biopharma Share News
0.000.00%
Last trade - 00:00- $154.70m
- $229.42m
- $102.48m
Brief: Sutro Biopharma Q2 Revenue USD 25.706 Million Vs. IBES Estimate USD 21 Million
Sutro Biopharma Inc expected to post a loss of 79 cents a share - Earnings Preview
Sutro Biopharma Inc reports results for the quarter ended in January - Earnings Summary
Brief: Sutro Biopharma Q1 Revenue USD 13.008 Million
Sutro Biopharma Inc expected to post a loss of 92 cents a share - Earnings Preview
U.S. RESEARCH ROUNDUP- Ally Financial, GE Vernova, Navient
Brief: Sutro Biopharma Announces Pricing Of $75 Mln Underwritten Offering
Brief: Ipsen And Sutro Biopharma Announce Licensing Agreement For Drug Targeting Solid Tumors
Sutro Biopharma Inc reports results for the quarter ended in December - Earnings Summary
Sutro Biopharma Inc expected to post a loss of 88 cents a share - Earnings Preview
Brief: Sutro Biopharma FY Revenue USD 153.731 Million
Brief: Sutro Biopharma Announces Positive Data From Use Luvelta In Pediatric Patients With Relapsed/Refractory Cbf/Glis
Brief: Vaxcyte Exercises Option And Enters Into Manufacturing Rights Agreement With Sutro Biopharma
Brief: Sutro Biopharma Promotes Jane Chung To President And Chief Operating Officer
Brief: Sutro Biopharma Files For Mixed Shelf Of Upto $300.0 Million - SEC Filing
Brief: Sutro Biopharma Q3 Revenue USD 16.924 Million
Sutro Biopharma Inc expected to post a loss of 74 cents a share - Earnings Preview
Brief: Sutro Biopharma Announces Presentation Of Data For Luvelta From Phase 1 Dose-Expansion Study In Endometrial Cancers At ESMO 2023
Brief: Adage Capital Partners, L.P. Reports 5.86% Passive Stake In Sutro Biopharma Inc As Of September 28 -SEC Filing